GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remed Co Ltd (XKRX:302550) » Definitions » PB Ratio

Remed Co (XKRX:302550) PB Ratio : 2.77 (As of Apr. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Remed Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), Remed Co's share price is ₩2785.00. Remed Co's Book Value per Share for the quarter that ended in Dec. 2023 was ₩1,006.13. Hence, Remed Co's PB Ratio of today is 2.77.

The historical rank and industry rank for Remed Co's PB Ratio or its related term are showing as below:

XKRX:302550' s PB Ratio Range Over the Past 10 Years
Min: 2.16   Med: 5   Max: 8.03
Current: 2.76

During the past 7 years, Remed Co's highest PB Ratio was 8.03. The lowest was 2.16. And the median was 5.00.

XKRX:302550's PB Ratio is ranked worse than
60.25% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs XKRX:302550: 2.76

During the past 12 months, Remed Co's average Book Value Per Share Growth Rate was 3.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 7.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 14.70% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Remed Co was 57.60% per year. The lowest was 4.90% per year. And the median was 16.75% per year.

Back to Basics: PB Ratio


Remed Co PB Ratio Historical Data

The historical data trend for Remed Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remed Co PB Ratio Chart

Remed Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial 3.12 8.03 6.23 2.53 3.24

Remed Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.53 2.61 2.91 3.66 3.24

Competitive Comparison of Remed Co's PB Ratio

For the Medical Devices subindustry, Remed Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remed Co's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Remed Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Remed Co's PB Ratio falls into.



Remed Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Remed Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=2785.00/1006.134
=2.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Remed Co  (XKRX:302550) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Remed Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Remed Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Remed Co (XKRX:302550) Business Description

Traded in Other Exchanges
N/A
Address
187 Techno 2-ro, No 301-303, Gwanpyeong-dong, Yuseong-gu, Daejeon, KOR, 34025
Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Remed Co (XKRX:302550) Headlines

No Headlines